Keyvan Ravakhah, MD
Internal Medicine · Cleveland, OHNPI 1346298569
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,800 of the $4,482 with a category attached, or 62.5%. Amgen accounts for 90.3% of it on its own, with 11 other manufacturers making up the rest. 2024 is the largest year on record at $3,955, more than ten times the $188 reported in 2019. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $104.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- Novo Nordisk$107
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$63
- Lilly USA, LLC$48
- Paratek Pharmaceuticals, Inc.$41
- Johnson & Johnson$40
- plus $137 from 6 others
What the payments were for
- Consulting fees$2,80062%
- Travel & lodging$90020%
- Food & beverage$78217%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 16 | $4,046 |
| Novo Nordisk | 7 | $107 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $63 |
| Lilly USA, LLC | 3 | $48 |
| Paratek Pharmaceuticals, Inc. | 2 | $41 |
| Johnson & Johnson | 3 | $40 |
| Dexcom, Inc. | 2 | $36 |
| Philips North America LLC | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Novartis | 1 | $21 |
| Pfizer | 1 | $14 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$3,844
How this compares
$4,482 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $185 |
| Metoprolol Succinate | 11 | $153 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Cleveland
- Cyrus HarrisCleveland$726K
- Marina MagreyCleveland$312K
- Joshua LonginowCleveland$241K
- Emad MansoorCleveland$219K
- Syed BukhariCleveland$165K
- Vadim KoshkinCleveland$159K
- Suresh Kumar BalasubramanianCleveland$148K
- Christine Tanaka-EspositoCleveland$123K
- Carla HarwellCleveland$75K
- Amr MohamedCleveland$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.